Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-20

Clinical Trial Update: Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial is assessing the efficacy of Songling Xuemaikang Capsules for Grade 1 essential hypertension; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Songling Xuemaikang Capsules

Snippet

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences | Conditions: Hypertension,Essential | Phase 4 | Status: RECRUITING